✦ LIBER ✦

Clinical value of urethane therapy in prostatic cancer

✍ Scribed by Jack Lapides

Publisher: John Wiley and Sons
Year: 1949
Tongue: English
Weight: 388 KB
Volume: 2
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(194905)2:3<469::aid-cncr2820020310>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant therapy in prostatic cancer

✍ PH Smith; MKB Parmar 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 1 views

Clinical diagnosis of prostate cancer

✍ Joseph D. Schmidt 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

Steroid response to therapy in prostatic

Steroid response to therapy in prostatic cancer

✍ Frederick B. Burt; Roy P. Finney; William Wallace Scott 📂 Article 📅 1957 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB 👁 1 views

Peptide analogs in the therapy of prosta

Peptide analogs in the therapy of prostate cancer

✍ Andrew V. Schally; Ana Maria Comaru-Schally; Artur Plonowski; Attila Nagy; Gabor 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

The use of peptide analogs in the therapy of prostate cancer is reviewed. The preferred primary treatment of advanced androgen-dependent prostate cancer is presently based on the use of depot preparations of LH-RH agonists. This treatment is likewise recommended in patients with rising PSA levels af

Evaluation and clinical value of neuroen

Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors

✍ Cussenot, Olivier; Villette, Jean-Marie; Cochand-Priollet, Beatrix; Berthon, Phi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

## BACKGROUND. Prostate cancer, like other solid tumors, is a rather heterogeneous entity. More than 50% of all malignant prostatic tumors contain neuroendocrine-like cells, which cannot be attributed to small cell prostatic carcinoma or carcinoid-like tumors, which represent only 1-2% of all prost

Epidemiologic determinants of clinically

Epidemiologic determinants of clinically relevant prostate cancer

✍ Margaret R. Spitz; Sara S. Strom; Yuko Yamamura; Patricia Troncoso; Richard J. B 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 67 KB 👁 1 views

While tumor volume and Gleason scores are the best available prognostic indicators for prostate cancer, contemporary predictive methods are unable to identify which men with Gleason scores of 7 have clinically insignificant tumors that will not progress and which men will develop highly aggressive p